Machine learning analysis of gene expression reveals TP53 Mutant-like AML with wild type TP53 and poor prognosis.

Abstract

Authors

• Yoonkyu Lee
  Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
• Linda B Baughn
  Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
• Chad L Myers
  Department of Computer Science and Engineering, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, United States.
• Zohar Sachs
  Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA. sachs038@umn.edu.

Keywords

External Resources